http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0196126-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fb9f44db08d1c42a53f3d28eaae416f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-00
filingDate 1987-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc4d33068b0827e35136bda77cbeb1e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c304e4505a366a5d992641d5fca2142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a30cc0eef7c5df46e3ac5d9571938c13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c712cb84269662d28ed2a753e817c30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab14a0b2c80700817922854eaf38fe9
publicationDate 1989-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0196126-A
titleOfInvention 5alpha-reductase inhibitor
abstract PURPOSE: To obtain 5α-reductase inhibitor of high safety, which is useful as a remedy or prophylactic for a variety of diseases male hormone participates, using flavonoids as an active ingredient. n CONSTITUTION: Flavonoids of formulas I and II (R 1 is H, OH, gulculonic acid residue; R 2 R 4 WR 8 are H, OH; R 3 is N, OH, saccharide residue) such as kaempherol, quercetin or vicalin is used as an active ingredient, to produce pharmaceutical preparations such as tablets, powder, granules, capsules, solution, spray, injection, ointment or suppository. In case of oral administration, the dose is 20W200mg/adult/day in one to several portions. It is used for hair tonic, sebaceous gland inhibitor, alopecia, hirsutism, hidradenitis suppurativa, prostatic hypertrophy, and prostatic cancer. n COPYRIGHT: (C)1989,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006347915-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000355525-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10194936-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106999528-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9848790-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013155126-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014505725-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012140348-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101273027-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9423717-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08510735-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2005027904-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007008885-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006199651-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09216827-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003055162-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0747048-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08510734-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07238037-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I731064-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6239170-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017531645-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0461827-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05255102-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014012645-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006232828-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5587176-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9918927-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5882658-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02076409-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017183581-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007086327-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6248751-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100692099-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6414017-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08157334-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0747048-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0648488-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007099751-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1047420-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017183581-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4577596-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1047420-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11501036-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0517321-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2769502-A1
priorityDate 1987-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9947828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453308282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409391

Total number of triples: 80.